| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EDWARDS LIFESCIENCES CORP | 34,069 | 4,844,000 | 28.53% | ||
| 2 | GILEAD SCIENCES INC | 17,162 | 1,685,000 | 9.92% | ||
| 3 | ACADIA PHARMACEUTICALS INC COM | 48,825 | 1,615,000 | 9.51% | ||
| 4 | LILLY ELI & CO | 16,844 | 1,410,000 | 8.30% | ||
| 5 | ARATANA THERAPEUTICS INC COM | 110,537 | 935,000 | 5.51% | ||
| 6 | DEXCOM | 9,794 | 841,000 | 4.95% | ||
| 7 | MEDICINES CO | 22,077 | 838,000 | 4.94% | ||
| 8 | REGENERON PHARMACEUTICALS | 1,756 | 817,000 | 4.81% | ||
| 9 | MALLINCKRODT PUB LTD CO SHS | 12,769 | 816,000 | 4.81% | ||
| 10 | INCYTE | 7,344 | 810,000 | 4.77% | ||
| 11 | MEDIVATION INC | 18,794 | 799,000 | 4.71% | ||
| 12 | NEUROCRINE BIOSCIE COM USD0.001 | 17,386 | 692,000 | 4.08% | ||
| 13 | AERIE PHARMACEUTICALS INC | 30,962 | 549,000 | 3.23% | ||
| 14 | UNITED THERAPEUTICS | 2,500 | 328,000 | 1.93% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-002002, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
